Were there any unusual items or oneâtime charges in the results that require adjustment for a normalized view of earnings?
Answer
The brief release for LiqTech Internationalâs Q2âŻ2025 results does not disclose any specific âunusual itemsâ or oneâtime charges. The summary only announces the filing of the results and provides no lineâitem detail (e.g., assetâwriteâdowns, restructuring costs, acquisitionârelated expenses, or gains/losses on disposals). Consequently, from the information available we cannot identify a nonârecurring component that would require an earnings normalization.
Implication for traders:
- Doâdiligence: Before forming a view on the companyâs normalized earnings (e.g., adjusted EBITDA or core EPS), obtain the full earnings release or the accompanying MD&A. Look for footnotes that flag items such as impairment of inventory, legal settlements, or other âspecialâ charges.
- Trading decision: Until the detailed financials are reviewed, it is prudent to hold off on any position that relies on a normalized earnings estimate. If a material oneâtime charge is uncovered, the market may have already priced it in; a subsequent âadjustedâ earnings call could create a shortâterm catalyst for a price move.
In short, based solely on the current news snippet, there is no evidence of unusual or oneâtime items; a deeper dive into the complete Q2âŻ2025 filing is required to confirm whether any adjustments are needed for a normalized earnings view.